Publications by authors named "Arno Floore"

Claim this Profile
F
FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years.
Frederique J Vink, Chris J L M Meijer, Albertus T Hesselink, Arno N Floore, Birgit I Lissenberg-Witte

Clin Infect Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classification of high-grade cervical intraepithelial neoplasia by p16 , Ki-67, HPV E4 and FAM19A4/miR124-2 methylation status demonstrates considerable heterogeneity with potential consequences for management.
Frederique J Vink, Stèfanie Dick, Daniëlle A M Heideman, Lise M A De Strooper, Renske D M Steenbergen, Arno Floore

Int J Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Collection Volume and DNA Extraction Method on the Detection of Biomarkers and HPV DNA in First-Void Urine.
Laura Téblick, Severien Van Keer, Annemie De Smet, Pierre Van Damme, Michelle Laeremans, Arno Floore

Molecules· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study.
Jesper Bonde, Arno Floore, Ditte Ejegod, Frederique J Vink, Albertus Hesselink

Int J Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FAM19A4/miR124-2 methylation in invasive cervical cancer: A retrospective cross-sectional worldwide study.
Frederique J Vink, Chris J L M Meijer, Gary M Clifford, Mario Poljak, Anja Oštrbenk, Arno N Floore

Int J Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlling technical variation amongst 6693 patient microarrays of the randomized MINDACT trial.
Laurent Jacob, Anke Witteveen, Inès Beumer, Leonie Delahaye, Diederik Wehkamp, Arno Floore

Commun Biol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra- and inter-laboratory agreement of the FAM19A4/mir124-2 methylation test: Results from an international study.
Arno Floore, Albertus Hesselink, Anja Oštrbenk, Elia Alcaniz, Beate Rothe

J Clin Lab Anal· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Equivalence of MammaPrint array types in clinical trials and diagnostics.
Inès Beumer, Anke Witteveen, Leonie Delahaye, Diederik Wehkamp, Mireille Snel, Arno Floore

Breast Cancer Res Treat· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance characteristics of the MammaPrint breast cancer diagnostic gene signature.
Leonie Jm Delahaye, Diederik Wehkamp, Arno N Floore, Rene Bernards, Laura J Van't Veer

Per Med· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor splice variants as a potential source of false-positive estrogen receptor status in breast cancer diagnostics.
Floris H Groenendijk, Wilbert Zwart, Arno Floore, Stephanie Akbari, Rene Bernards

Breast Cancer Res Treat· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiling guiding diagnosis and therapy of rare mammary-like anogenital gland carcinomas.
Peter Gunvén, Margareta Randén, Göran Elmberger, Béla Bozóky, Arno Floore

Med Oncol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of histopathological and gene expression-based typing of cancer of unknown primary.
Lars Morawietz, Arno Floore, Lisette Stork-Sloots, Gunnar Folprecht, Reinhard Buettner

Virchows Arch· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a novel microarray-based diagnostic test for cancer of unknown primary.
Ryan K van Laar, Xiao-Jun Ma, Daphne de Jong, Diederik Wehkamp, Arno N Floore

Int J Cancer· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A gene expression profile for detection of sufficient tumour cells in breast tumour tissue: microarray diagnosis eligibility.
Paul Roepman, Arenda Schuurman, Leonie J M J Delahaye, Anke T Witteveen, Arno N Floore

BMC Med Genomics· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study.
Stella Mook, Marjanka K Schmidt, Giuseppe Viale, Giancarlo Pruneri, Inge Eekhout, Arno Floore

Breast Cancer Res Treat· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer.
Paul Roepman, Jacek Jassem, Egbert F Smit, Thomas Muley, Jacek Niklinski, Arno Floore

Clin Cancer Res· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary.
Hugo M Horlings, Ryan K van Laar, Jan-Martijn Kerst, Helgi H Helgason, Jelle Wesseling, Arno Floore

J Clin Oncol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).
Jolien M Bueno-de-Mesquita, Wim H van Harten, Valesca P Retel, Laura J van 't Veer, Frits Sam van Dam, Arno N Floore

Lancet Oncol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robust interlaboratory reproducibility of a gene expression signature measurement consistent with the needs of a new generation of diagnostic tools.
Robert A Ach, Arno Floore, Bo Curry, Vladimir Lazar, Annuska M Glas

BMC Genomics· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Converting a breast cancer microarray signature into a high-throughput diagnostic test.
Annuska M Glas, Arno Floore, Leonie J M J Delahaye, Anke T Witteveen, Rob C F Pover

BMC Genomics· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer.
Marc Buyse, Sherene Loi, Laura van't Veer, Giuseppe Viale, Mauro Delorenzi, Arno Floore

J Natl Cancer Inst· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late-onset common cancers in a kindred with an Arg213Gln TP53 germline mutation.
Mariëlle W G Ruijs, Senno Verhoef, Gea Wigbout, Roelof Pruntel, Arno N Floore

Fam Cancer· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tamoxifen resistance by a conformational arrest of the estrogen receptor alpha after PKA activation in breast cancer.
Rob Michalides, Alexander Griekspoor, Astrid Balkenende, Desiree Verwoerd, Lennert Janssen, Arno Floore

Cancer Cell· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are ATM mutations 7271T-->G and IVS10-6T-->G really high-risk breast cancer-susceptibility alleles?
Csilla I Szabo, Mieke Schutte, Annegien Broeks, Jeanine J Houwing-Duistermaat, Yvonne R Thorstenson, Arno N Floore

Cancer Res· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IVS10-6T>G, an ancient ATM germline mutation linked with breast cancer.
Annegien Broeks, Jos H M Urbanus, Peter de Knijff, Peter Devilee, Marion Nicke, Arno N Floore

Hum Mutat· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis